Dysphagia Management During COVID-19 Pandemic
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04509752 |
Recruitment Status :
Not yet recruiting
First Posted : August 12, 2020
Last Update Posted : August 12, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dysphagia Covid19 | Other: Survey |
Study Type : | Observational |
Estimated Enrollment : | 50 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Experiences in Dysphagia Management During COVID-19 Pandemic |
Estimated Study Start Date : | August 20, 2020 |
Estimated Primary Completion Date : | November 15, 2020 |
Estimated Study Completion Date : | November 30, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
Dysphagia clinicians
Clinicians from swallowing centers (from all over the world)
|
Other: Survey
An online survey will be sent to each clinic to answer the survey questions. |
- Online survey [ Time Frame: 3 months ]An online survey will be designed to understand the current clinical conditions and current practice regarding dysphagia management during the pandemic period/normalization period

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Working on a dysphagia clinic from all over the world
Exclusion Criteria:
- Not willing to participate
- Not working on a dysphagia clinic

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04509752
Contact: SELEN SEREL ARSLAN | +905356643007 | selen.serel@hacettepe.edu.tr | |
Contact: NUMAN DEMİR | +905424848079 | numan@hacettepe.edu.tr |
Turkey | |
Hacetttepe University | |
Ankara, Turkey, 06100 |
Principal Investigator: | SELEN SEREL ARSLAN | Hacettepe University |
Responsible Party: | SELEN SEREL ARSLAN, Principal Investigator, Hacettepe University |
ClinicalTrials.gov Identifier: | NCT04509752 |
Other Study ID Numbers: |
Dysphagia during COVID-19 |
First Posted: | August 12, 2020 Key Record Dates |
Last Update Posted: | August 12, 2020 |
Last Verified: | August 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
dysphagia COVID-19 |
Deglutition Disorders Esophageal Diseases Gastrointestinal Diseases |
Digestive System Diseases Pharyngeal Diseases Otorhinolaryngologic Diseases |